The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
General
Multi-service telehealth platform covering urgent care, STD and STI care, weight loss, primary care, and dermatology. General telehealth visits outside weight loss are $39.99.
Three weight-loss care options: Full Strength and Micro-Dosing All-In-One programs ship compounded medication to the home each month with provider management, while Care-Only sends a prescription to the patient's local pharmacy for brand drugs paid by insurance or cash.